158 related articles for article (PubMed ID: 30574903)
21. Efficacy of anti-VEGF intravitreal injection in traumatic submacular hemorrhage: a retrospective study.
Wang J; Huang L; Chen L; Chen S; Liu S
Int Ophthalmol; 2024 Jun; 44(1):259. PubMed ID: 38909337
[TBL] [Abstract][Full Text] [Related]
22. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
[TBL] [Abstract][Full Text] [Related]
23. DIFFERENCE IN TREATMENT OUTCOMES ACCORDING TO OPTICAL COHERENCE TOMOGRAPHY-BASED STAGES IN TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION).
Kim JH; Chang YS; Kim JW; Kim CG; Lee DW; Cho SY
Retina; 2018 Dec; 38(12):2356-2362. PubMed ID: 29019795
[TBL] [Abstract][Full Text] [Related]
24. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
25. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
26. PROGRESSION OF RETINAL ISCHEMIA IN A CASE OF MACULAR TELANGIECTASIA TYPE 1 AFTER RANIBIZUMAB INJECTION: OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS.
Lorusso M; Zito R; Nikolopoulou E; Micelli Ferrari L; Cicinelli MV; Querques G; Micelli Ferrari T
Retin Cases Brief Rep; 2020; 14(4):372-376. PubMed ID: 29443804
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
Tzaridis S; Hess K; Friedlander M; Holz FG
Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
[TBL] [Abstract][Full Text] [Related]
28. Early Changes of Retinal Morphology in Therapy of Neovascular Age-Related Macular Degeneration with Three Commonly Used Anti-VEGF Agents.
Enders P; Sitnilska V; Altay L; Fauser S
Ophthalmologica; 2018; 239(1):45-51. PubMed ID: 28950272
[TBL] [Abstract][Full Text] [Related]
29. Foveal microvascular anomalies on optical coherence tomography angiography and the correlation with foveal thickness and visual acuity in retinopathy of prematurity.
Chen YC; Chen YT; Chen SN
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):23-30. PubMed ID: 30361765
[TBL] [Abstract][Full Text] [Related]
30. Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.
Shin JY; Woo SJ; Ahn J; Park KH
Korean J Ophthalmol; 2013 Dec; 27(6):425-32. PubMed ID: 24311928
[TBL] [Abstract][Full Text] [Related]
31. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
[TBL] [Abstract][Full Text] [Related]
32. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography.
Lee DH; Kang HG; Lee SC; Kim M
Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301
[TBL] [Abstract][Full Text] [Related]
33. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
34. Profiling neovascular age-related macular degeneration choroidal neovascularization lesion response to anti-vascular endothelial growth factor therapy using SSOCTA.
Told R; Reiter GS; Mittermüller TJ; Schranz M; Reumueller A; Schlanitz FG; Weigert G; Pollreisz A; Sacu S; Schmidt-Erfurth U
Acta Ophthalmol; 2021 Mar; 99(2):e240-e246. PubMed ID: 32706171
[TBL] [Abstract][Full Text] [Related]
35. Outer retinal tubulations response to anti-VEGF treatment.
Espina M; Arcinue CA; Ma F; Camacho N; Barteselli G; Mendoza N; Ferrara N; Freeman WR
Br J Ophthalmol; 2016 Jun; 100(6):819-23. PubMed ID: 26423451
[TBL] [Abstract][Full Text] [Related]
36. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
37. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
38. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.
Sellam A; Glacet-Bernard A; Coscas F; Miere A; Coscas G; Souied EH
Retina; 2017 Jun; 37(6):1176-1184. PubMed ID: 27685676
[TBL] [Abstract][Full Text] [Related]
39. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
40. Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection.
Kang YK; Park HS
Korean J Ophthalmol; 2020 Apr; 34(2):168-169. PubMed ID: 32233152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
